DBV Technologies S.A.

(DBVT) Trade

By |

Profile

DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.

Contact Information

Website: www.dbv-technologies.com
Email: investors@dbv-technologies.com
Main Phone: +33 155427878
Address: 177-181 avenue Pierre Brossolette
City / Town: Montrouge
Country: FRA
Postal Code: 92120

Issuer Information

Exchange: NGS
CEO: Pierre-Henri Benhamou
Employees: 244
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.39 $ 0.43 (3.08%)
Last Price 14.39 Change $ 0.43 Change % 3.08 Tick N/A
Bid N/A Bid Size 0.00 Ask 19.95 Ask Size 400.00
Open 14.49 High 14.55 Low 14.20 Prev Close 13.96
Last Trade Volume 97,037 52 Wk Hi 26.98 52 Wk Low 13.51
Market Cap 866.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,230,434.00 EPS (TTM) -3.58 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 57 57 57 57
Low Target Price Estimate 27 27 27 27
Mean Target Price Estimate 40.43 40.43 40.43 40.43
Standard Deviation 11.52 11.52 11.52 11.52
Date of Most Recent Estimate 05/29/18 05/29/18 04/27/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 8 7
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.44 1.44 1.4 1.44